Top compounds associated with response to ADAM22


Feature Type Standardized
Nominal ANOVA
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.17 5e-07
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-07
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA SU11274 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.16 2e-06
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA vincristine CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA Topotecan CTRPv2 pan-cancer AAC 0.17 2e-06
Download CSV